OpenVSafe by OpenVAERS
Search V-safe

5CZ-38327-33525

5 vaccinations 5 coded responses 23 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
210 / MD
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-19
    Registered in v-safe
  2. 2021-01-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-02
    Survey response — day 14, dose 1
    MedDRA: Chillblains, Vitreous floaters — Feeling: Good
    Free text: Worsening of a vitreous floater in left eye. Also getting chilblains in toes after even short cold exposures.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-09
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-23
    Survey response — day 7, dose 2
    MedDRA: Injection site pain, Night sweats — Feeling: Good
    Free text: Had pain at injection site and night sweats first 2 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-04
    Survey response — day 21, dose 2
    MedDRA: Chillblains — Feeling: Good
    Free text: Occasional chillblains appearance in some of toes in both feet, with good capillary refill. No fever, chills, respiratory symptoms, or similar symptoms in fingers.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-11
    Survey response — day 28, dose 2
    MedDRA: Fatigue, Sensory disturbance — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fluctuating dusky changes in toes. Capillary return is OK and foot pulses are unchanged from baseline. Getting tired easily doing yard work but exercise at the gym is okay.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-08-16
    Dose 3 — Pfizer-BioNTech
  21. 2021-09-30
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  22. 2021-11-15
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-02-08
    Dose 4 — Pfizer-BioNTech
  24. 2022-02-14
    Survey response — 6 months, dose 3
    MedDRA: Fatigue, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Had fatigue and questionable COVID toes for 2-3 days a couple of weeks ago. Good foot pulses, no cough / fever / headache / myalgias. Home rapid tests negative x 4. Did not get PCR done.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-08-16
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-08-16
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  27. 2022-09-16
    Dose 5 — Moderna
  28. 2023-02-08
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in
  29. 2023-03-17
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Pfizer-BioNTech
22021-02-11Pfizer-BioNTech
32021-08-16Pfizer-BioNTech No
42022-02-08Pfizer-BioNTech No
52022-09-16Moderna No

Free text

Release 3 — day 14, dose 1

2021-02-02

Symptoms: Worsening of a vitreous floater in left eye. Also getting chilblains in toes after even short cold exposures.

Release 4 — day 7, dose 2

2021-02-23

Systemic reaction (other): Had pain at injection site and night sweats first 2 days

Release 5 — day 21, dose 2

2021-03-04

Symptoms: Occasional chillblains appearance in some of toes in both feet, with good capillary refill. No fever, chills, respiratory symptoms, or similar symptoms in fingers.

Release 5 — day 28, dose 2

2021-03-11

Symptoms: Fluctuating dusky changes in toes. Capillary return is OK and foot pulses are unchanged from baseline. Getting tired easily doing yard work but exercise at the gym is okay.

Release 11 — 6 months, dose 3

2022-02-14

Symptoms: Had fatigue and questionable COVID toes for 2-3 days a couple of weeks ago. Good foot pulses, no cough / fever / headache / myalgias. Home rapid tests negative x 4. Did not get PCR done.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChillblains ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDPre-existing disease · · ✓
SDSensory disturbance ✓ ✓ ✓
SDVitreous floaters ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SRONight sweats ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release